Smiths to take FreeStyle to the US:
This article was originally published in Clinica
Executive Summary
Smiths Medical is set to market and distribute Abbott's recently FDA-approved FreeStyle Navigator continuous glucose monitoring system in the US. The non-exclusive distribution deal will see Smiths add the FreeStyle Navigator system to its diabetes product portfolio, which includes the CozMore "all-in-one" blood glucose monitoring and insulin pump system, and the Deltec Cozmo insulin pump. The FreeStyle Navigator system, approved by the FDA in March, is designed to improve diabetes management by continually recording interstitial fluid glucose levels through a sensor worn under the patient's skin for five days. Financial terms of the deal were not disclosed.